We are delighted to continue the tradition of highlighting our incredible summer interns. To kick off the series, this week we are spotlighting: · Marguerite Eno, Discovery Biology Intern, who is a student at Northwestern University studying Biomedical/Medical Engineering · Colby Girard, Chemistry Intern, who recently graduated from Tufts University with a BS in Biochemistry & Biotechnology Swipe through the graphic to learn more about their experience at Entrada. Recent grads, learn more about our current openings: https://lnkd.in/eXjmC27B #EntradaHere #Internship #TopPlaceToWork
Entrada Therapeutics
Biotechnology Research
Boston, MA 23,003 followers
Innovating to transform the treatment of devastating diseases through intracellular therapeutics.
About us
Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of active moieties into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, we are advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others. Our lead oligonucleotide programs are in development for the treatment of people living with Duchenne muscular dystrophy who are exon 44, 45 and 50 skipping amenable. Entrada has partnered VX-670, a clinical-stage program for the treatment of myotonic dystrophy type 1. For more information about Entrada, please visit our website, www.entradatx.com
- Website
-
https://www.entradatx.com/
External link for Entrada Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 2016
Locations
-
Primary
One Design Center
Boston, MA 02210, US
Employees at Entrada Therapeutics
Updates
-
Last week, Entrada traveled north to attended the Skeletal Muscle Stem Cells in Development Regenerations & Adaptations conference in Estérel, Québec. Nelsa Estrella, Ph.D., Director, Neuromuscular Therapeutics, presented a poster titled, “Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD Cell Model”. To view the full poster, click here: https://lnkd.in/ed8345DB #EntradaHere #DMD
-
Looking for an opportunity to make an impact? Join us! As a member of the Entrada team, you'll have the chance to work on emerging technology and make a difference in the lives of patients and their families. Together, we are working to shape the future of intracellular therapeutics. Apply today: https://lnkd.in/eXjmC27B Featured Roles: • Senior Scientist II, Bioanalytical #EntradaHere #NowHiring #TopPlaceToWork
-
If you’ve been following us over the years, you know a beloved Entrada tradition is our annual summer boat party. For the last three years, we have increasingly joked about needing a larger boat. As of last week, that day has officially come. The Entrada team came together at Lawn On D in the Boston Seaport for our summer party on what felt like the hottest day of the year. Although leaving the boat behind is bittersweet, our new location (and the continued growth that it represents) is an important milestone for our team. We’d like to thank everyone who has supported us on this journey and all the Entradans who braved the heatwave. #GoTeam #popsicles Learn more about what it is like to work at Entrada: https://lnkd.in/eMt4CsU #EntradaHere #Summer2024
-
A round of applause for this group of recently promoted Entradans! 👏🏽👏🏾👏🏿👏🏻 Each one of you exemplify the core values of Entrada – endless curiosity, tenacity and creativity. Together, our incredible team drives scientific innovation with the shared goal of making a meaningful difference for patients and their families. We’re looking forward to seeing your next achievements. Alex Bonanno, Amanda Dombroski, Eric T. Williams, Ph.D., Kimberli Kamer, Molly O'Connor, CPA, Mufan Xu, Nelsa Estrella, Ph.D., Nick Long, Patrick Dougherty, Pauline Tan, PhD, Sara B., Silvia Pasini, PhD, Varick Ho, Wenlong (Bill) Lian, Zekun Liu Interested in joining our team? Apply here: https://lnkd.in/eXjmC27B #EntradaHere #CareerGrowth #TopPlaceToWork
-
Entrada Therapeutics reposted this
Last week I had the privilege of talking with Yuva G., Entrada’s remarkable Finance and Accounting Intern. Yuva is attending the University of Pennsylvania as a cognitive science, computation and cognition major and also, as he says, “living life to the fullest despite Duchenne muscular dystrophy”. It is not every day that we get an opportunity to bring on an intern who lives with the disease that our teams are so persistent in finding treatments for, especially one as talented as Yuva. Yuva shared so many amazing insights on life and learning. We also discussed the ways we can continue building upon patient-focused drug development, advancing accessibility and inclusivity for all and taking a moment to focus on what really matters to each of us. Thank you to Yuva G., from the entire Entrada team!
-
Next week, Entrada will be attending the Skeletal Muscle Stem Cells in Development Regenerations & Adaptations conference on July 14-19, 2024, in Estérel, Québec. Nelsa Estrella, Ph.D., Associate Director, Neuromuscular Therapeutics, will be presenting a poster titled, “Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD Cell Model”. We hope to see you there! Learn more about our scientific presentations and manuscripts: https://lnkd.in/ed8345DB #EntradaHere #DMD
-
Supporting our employees' career development is a core focus at Entrada. Sometimes, this means encouraging and celebrating colleagues whose next step is moving beyond Entrada. We are proud of our newest #EntradaAlumni as they head back to school to start advanced degree programs at Tufts University, Northeastern University School of Law and University College Cork. Congratulations to Alison Burman, Emily Kealey and Kayla Gunning. We will always be rooting for you! Learn more about what it's like to work with us: https://lnkd.in/eMt4CsU #EntradaHere #BackToSchool #Biotech
-
#ICYMI: The Entrada team attended the 6th Annual RNA Therapeutics Conference. Xiulong (Mark) Shen, Senior Scientist II, Discovery Research, presented a poster titled, “Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle”. The event was a great opportunity to connect with colleagues and discuss the latest innovations in RNA therapeutics. #EntradaHere #Biotech
-
Final call for applications! This Friday is the last day to apply for the Entrada Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program. Entrada DREAMS is awarding three grants of $25,000 (USD) each to U.S. based non-profit organizations with project proposals that embrace diversity, inclusivity, accessibility and the creation or expansion of vital services to achieve greater equality within the Duchenne community. The deadline to submit an application is Friday, July 12, 2024, at 11:45pm ET. To learn more and apply visit: www.entradatx.com/dreams. #EntradaDREAMS #EntradaHere #DMD